TransUnion Company Profile (NYSE:TRU)

TransUnion trades on the New York Stock Exchange (NYSE) under the ticker symbol "TRU."

TransUnion announced that its board has initiated a share repurchase plan on Tuesday, April 11th 2017, which authorizes the company to buyback $300,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 4.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its stock is undervalued.

TransUnion (NYSE:TRU) posted its quarterly earnings data on Tuesday, July, 25th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.44 by $0.03. The firm had revenue of $474.80 million for the quarter, compared to the consensus estimate of $464.77 million. TransUnion had a return on equity of 20.32% and a net margin of 12.08%. The company's revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. View TransUnion's Earnings History.

TransUnion is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for TransUnion.

TransUnion issued an update on its third quarter earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of 0.45-0.46 for the period, compared to the Thomson Reuters consensus estimate of $0.46. The company issued revenue guidance of $470-475 million, compared to the consensus revenue estimate of $472.58 million.

7 equities research analysts have issued twelve-month price targets for TransUnion's stock. Their predictions range from $42.00 to $50.00. On average, they expect TransUnion's share price to reach $46.14 in the next twelve months. View Analyst Ratings for TransUnion.

Here are some recent quotes from research analysts about TransUnion stock:

• 1. According to Zacks Investment Research, "TransUnion reported solid second-quarter 2017 results with healthy improvement in earnings and revenues that also beat the respective Zacks Consensus Estimates. The company is poised for impressive growth in several of its end markets with an attractive business model, significant operating leverage, low capital requirements and strong and stable cash flows. Increased risk of identity theft due to data breaches and higher consumer awareness about the usage of credit information are propelling the demand for its consumer solutions. With solid quarterly results and favourable growth dynamics, the company also raised its guidance for 2017. TransUnion has outperformed the industry year to date. However, it is vulnerable to the overall macroeconomic conditions, industry trends, seasonality issues, adverse foreign currency translation effects and developments in the credit market, which limit its profitability to some extent." (7/27/2017)
• 2. Stifel Nicolaus analysts commented, "There just isn't much to pick on, in our view, and continued strong underlying fundamentals remain intact. While all the key metrics in our model are improving, we believe the strong FCF generation that is starting to come through is of particular note. We would expect the company to generate $900M-$1B of FCF in the next three years, and after accounting for $300M in share repurchases and $150M of required debt repayments, we expect ample opportunity for incremental value enhancing activities including continued M&A, and potentially additional share repurchases. If management wanted to keep the senior leverage ratio constant to the current level, we believe there would be over $1.2B-$1.3B of FCF available (after share repurchases) for M&A or additional share repurchases (in the context of FCF generation capacity in the next three years, $300M actually seems pretty wimpy). We reiterate our Buy rating on the shares and increase our target price from $39 to $43. Our target price assumes a one-turn EV/EBITDA multiple discount to EFX's valuation on 2017 and 2018 estimates." (2/15/2017)

TransUnion saw a increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,853,183 shares, an increase of 153.3% from the June 15th total of 1,126,567 shares. Based on an average daily trading volume, of 1,396,292 shares, the short-interest ratio is currently 2.0 days. Approximately 1.7% of the company's stock are sold short.

Some companies that are related to TransUnion include Broadridge Financial Solutions (BR), FactSet Research Systems (FDS), CoreLogic (CLGX), John Wiley & Sons (JW.A), Elevate Credit (ELVT), Ebiquity plc (EBQ), China Finance Online Co. Limited (JRJC), TheStreet (TST), Everyday Health (EVDY), IHS (IHS) and S&P Global (MHP).

TransUnion's management team includes the folowing people:

• James M. Peck, President, Chief Executive Officer, Director
• Samuel A. Hamood, Chief Financial Officer, Executive Vice President
• John W. Blenke, Executive Vice President, General Counsel
• Christopher A. Cartwright, Executive Vice President - U.S. Information Services
• John T. Danaher, Executive Vice President - Consumer Interactive
• Gerald M. McCarthy Jr., Executive Vice President - Healthcare
• David M. Neenan, Executive Vice President - International
• Suzanne P. Clark, Director
• Christopher Egan, Director
• Siddharth N. Mehta, Director

(TRU) raised $651 million in an initial public offering on Thursday, June 25th 2015. The company issued 29,600,000 shares at $21.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Deutsche Bank Securities, RBC Capital Markets, Wells Fargo Securities and Credit Suisse acted as the underwriters for the IPO and Drexel Hamilton, Evercore ISI, Loop Capital Markets and Stifel were co-managers.

TransUnion's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Egerton Capital UK LLP (1.17%), Independent Franchise Partners LLP (1.01%), Russell Investments Group Ltd. (0.34%), KAMES CAPITAL plc (0.02%), Highland Capital Management LLC (0.01%) and Great West Life Assurance Co. Can (0.01%). Company insiders that own TransUnion stock include Christopher Egan, David M Neenan, George M Awad, Gerald M Mccarthy, Jr, International Corp/Ma Advent, James M Peck, John T Danaher, John W Blenke, Samuel A Hamood, Sumit Rajpal and Timothy Elberfeld. View Institutional Ownership Trends for TransUnion.

TransUnion's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Bank of Montreal Can, US Bancorp DE, KAMES CAPITAL plc and Parametrica Management Ltd. Company insiders that have sold TransUnion stock in the last year include Christopher Egan, David M Neenan, George M Awad, Gerald M Mccarthy, Jr, International Corp/Ma Advent, James M Peck, John T Danaher, John W Blenke, Samuel A Hamood, Sumit Rajpal and Timothy Elberfeld. View Insider Buying and Selling for TransUnion.

TransUnion's stock was purchased by a variety of institutional investors in the last quarter, including Egerton Capital UK LLP, Independent Franchise Partners LLP, Highland Capital Management LLC, World Asset Management Inc, Schmidt P J Investment Management Inc., Public Employees Retirement Association of Colorado, NGAM Advisors L.P. and Great West Life Assurance Co. Can. View Insider Buying and Selling for TransUnion.

Shares of TransUnion can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TransUnion stock can currently be purchased for approximately $45.29.